FDA Inspection 679432 — The University Of Texas MD Anderson Cancer Center IRB
The FDA completed an inspection of The University Of Texas MD Anderson Cancer Center IRB on Aug 19, 2010 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 19, 2010
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Houston, TX (United States)
Additional Details
IRB